Hologic News (NASDAQ:HOLX)

DateTimeSource
Headline
11/14/20174:01PMPRNUSHologic Announces Upcoming Put Option and Notice of Redemption of 2.00% Convertible Senior Notes Due 2043
Hologic Announces Upcoming Put Option and Notice of Redemption of 2.00% Convertible Senior Notes Due 2043 PR Newswire MARLBOROUGH, Mass., Nov. 14, 2017 MARLBOROUGH, Mass., Nov. 14, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that holders of the 2.00% Convertible Senior Notes due 2043 (CUSIP No. 436440... More...>>
11/08/20174:01PMPRNUSHologic Announces Financial Results for Fourth Quarter of Fiscal 2017
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 -- Company Posts Revenue of $802.9 Million, GAAP Diluted EPS of $0.29, and Non-GAAP Diluted EPS of $0.50 -- -- $306 Million of Capital Redeployed to Repurchase Shares, Reduce Convertible Debt in Fourth Quarter -- PR Newswire MARLBOROUGH, Mass., Nov... More...>>
11/06/20178:10AMPRNUSHologic to Webcast Presentations at Upcoming Investor Conferences
Hologic to Webcast Presentations at Upcoming Investor Conferences PR Newswire MARLBOROUGH, Mass., Nov. 6, 2017 MARLBOROUGH, Mass., Nov. 6, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The Stifel 2017 Healthcare Conference in New... More...>>
11/01/20178:07AMPRNUSHologic Launches the MyoSure® MANUAL Device to Help Doctors Remove Intrauterine Tissue In-Office
Hologic Launches the MyoSure® MANUAL Device to Help Doctors Remove Intrauterine Tissue In-Office PR Newswire MARLBOROUGH, Mass., Nov. 1, 2017 MARLBOROUGH, Mass., Nov. 1, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today the U.S. launch of the MyoSure® MANUAL device, which was designed to help doctors... More...>>
10/26/20178:07AMPRNUSParaflu Assay Now FDA Cleared on Hologic's New Panther Fusion® System
Paraflu Assay Now FDA Cleared on Hologic's New Panther Fusion® System -- New Assay Extends Respiratory Testing Menu; Modular Panels and Fusion System Increase Efficiency and Flexibility for the Laboratory -- PR Newswire MARLBOROUGH, Mass., Oct. 26, 2017 MARLBOROUGH, Mass., Oct. 26, 2017 /PRNewswire/ -- Hologic, Inc... More...>>
10/17/20173:00AMPRNUSHologic Receives CE Mark to Market SculpSure® for Non-Invasive Body Contouring (Lipolysis) of the Submental Area (Under the ...
Hologic Receives CE Mark to Market SculpSure® for Non-Invasive Body Contouring (Lipolysis) of the Submental Area (Under the Chin) PR Newswire MARLBOROUGH, Massachusetts, Oct. 17, 2017 Patients in Clinical Studies Report 100% Satisfaction MARLBOROUGH, Massachusetts, Oct. 17, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq:... More...>>
10/05/20174:01PMPRNUSPanther Fusion® Flu A/B/RSV Assay Now FDA Cleared on Hologic's New Panther Fusion® System
Panther Fusion® Flu A/B/RSV Assay Now FDA Cleared on Hologic's New Panther Fusion® System - New Panther Fusion Module Expands System's Molecular Testing Capabilities, Increases Efficiency and Flexibility for the Laboratory PR Newswire MARLBOROUGH, Mass., Oct. 5, 2017 MARLBOROUGH, Mass., Oct. 5, 2017 /PRNewswire/ -- Hologic... More...>>
10/04/20176:01PMPRNUSHologic Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 4.375% Senior Notes Due 2025
Hologic Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 4.375% Senior Notes Due 2025 PR Newswire MARLBOROUGH, Mass., Oct. 4, 2017 MARLBOROUGH, Mass., Oct. 4, 2017 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) announced today that it has priced its previously announced private offering of $350... More...>>
10/04/20177:02AMPRNUSHologic Enters into Amended and Restated Five-Year Secured Credit Agreement
Hologic Enters into Amended and Restated Five-Year Secured Credit Agreement - Initial Proceeds from New $1.5 Billion Term Loan and $1.5 Billion Revolving Credit Line Used to Refinance Senior Secured Debt - - Funds Also Expected to Contribute to Retirement of Remaining Convertible Notes - PR Newswire MARLBOROUGH, Mass... More...>>
10/04/20177:02AMPRNUSHologic Announces Offering of $350 Million of Senior Notes Due 2025
Hologic Announces Offering of $350 Million of Senior Notes Due 2025 - Proceeds Expected to Contribute to Retirement of Remaining Convertible Notes - PR Newswire MARLBOROUGH, Mass., Oct. 4, 2017 MARLBOROUGH, Mass., Oct. 4, 2017 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) announced today that it has launched, subject to... More...>>
10/03/20174:01PMPRNUSHologic to Announce Financial Results for the Fourth Quarter of Fiscal 2017 on Wednesday, November 8, 2017
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2017 on Wednesday, November 8, 2017 PR Newswire MARLBOROUGH, Mass., Oct. 3, 2017 MARLBOROUGH, Mass., Oct. 3, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter... More...>>
09/29/201711:06AMGLOBEHologic, Inc. (Nasdaq: HOLX) to Ring The Nasdaq Stock Market Opening Bell
ADVISORY, Sept. 29, 2017 (GLOBE NEWSWIRE) -- What: Hologic, Inc. (Nasdaq:HOLX), an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment, will visit the Nasdaq MarketSite in Times Square in conjunction with the start of Breast Cancer Awareness... More...>>
09/29/20178:07AMPRNUSHologic CEO Steve MacMillan to Ring Nasdaq Opening Bell on October 2 to Kick Off Breast Cancer Awareness Month
Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell on October 2 to Kick Off Breast Cancer Awareness Month Trailblazing Company Behind the Genius™ 3D Mammography™ Exam Celebrates Year of Innovations in Breast Health PR Newswire MARLBOROUGH, Mass., Sept. 29, 2017 MARLBOROUGH, Mass., Sept. 29, 2017 /PRNewswire/ -- Hologic... More...>>
09/27/20178:00AMPRNUSHologic Receives FDA 510(k) Clearance to Market SculpSure® for Non-Invasive Body Contouring (Lipolysis) of the Submental Are...
Hologic Receives FDA 510(k) Clearance to Market SculpSure® for Non-Invasive Body Contouring (Lipolysis) of the Submental Area (Under the Chin) Patients in Clinical Studies Report 100% Satisfaction Rate PR Newswire MARLBOROUGH, Mass., Sept. 27, 2017 MARLBOROUGH, Mass., Sept. 27, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq:... More...>>
09/26/20178:07AMPRNUSHologic Introduces a More Comfortable Mammogram with the Launch of the SmartCurve™ Breast Stabilization System
Hologic Introduces a More Comfortable Mammogram with the Launch of the SmartCurve™ Breast Stabilization System 93% of Women Surveyed Reported Improved Comfort with the New System* PR Newswire MARLBOROUGH, Mass., Sept. 26, 2017 MARLBOROUGH, Mass., Sept. 26, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) today announced... More...>>
09/14/20178:12AMPRNUSNew USPSTF Draft Cervical Cancer Screening Recommendations Are a Step Back for Women's Health, Would Put Lives at Risk
New USPSTF Draft Cervical Cancer Screening Recommendations Are a Step Back for Women's Health, Would Put Lives at Risk PR Newswire MARLBOROUGH, Mass., Sept. 14, 2017 MARLBOROUGH, Mass., Sept. 14, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) is deeply concerned that the United States Preventive Services Task Force... More...>>
09/11/20178:00AMPRNUSHologic's 3Dimensions™ Mammography System Now Available in Europe
Hologic's 3Dimensions™ Mammography System Now Available in Europe PR Newswire MARLBOROUGH, Massachusetts, Sept. 11, 2017 Fastest, Highest Resolution Breast Tomosynthesis System is Designed to Increase Clinical Confidence, Accuracy and Patient Comfort MARLBOROUGH, Massachusetts, Sept. 11, 2017 /PRNewswire/ -- Hologic... More...>>
08/31/20178:00AMPRNUSHologic Announces Availability of New Brevera® Breast Biopsy System with CorLumina® Imaging Technology
Hologic Announces Availability of New Brevera® Breast Biopsy System with CorLumina® Imaging Technology Transformational Workflow Solution Offers Real-Time Imaging of Tissue Samples, Resulting in Major Cost and Time Savings PR Newswire MARLBOROUGH, Mass., Aug. 31, 2017 MARLBOROUGH, Mass., Aug. 31, 2017 /PRNewswire/... More...>>
08/02/20174:01PMPRNUSHologic Announces Financial Results for Third Quarter of Fiscal 2017
Hologic Announces Financial Results for Third Quarter of Fiscal 2017 -- Company Posts Revenue of $806.1 Million, GAAP Diluted EPS of $0.21, and Non-GAAP Diluted EPS of $0.50 -- -- Organic Revenue Growth Led by Molecular Diagnostics and International Businesses -- PR Newswire MARLBOROUGH, Mass., Aug. 2, 2017 MARLBOROUGH... More...>>
07/31/20174:01PMPRNUSHologic to Webcast Presentations at Upcoming Investor Conferences
Hologic to Webcast Presentations at Upcoming Investor Conferences PR Newswire MARLBOROUGH, Mass., July 31, 2017 MARLBOROUGH, Mass., July 31, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The Canaccord Genuity Growth Conference in... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V:us D:20171117 19:30:45